These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31155026)

  • 1. Evaluation of Direct Oral Anticoagulant Dosing and Monitoring in Two Geriatric Outpatient Clinics.
    Howerton MA; Suhrie EM; Gennari AS; Jones N; Ruby CM
    Sr Care Pharm; 2019 Mar; 34(3):192-205. PubMed ID: 31155026
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation.
    Rymer JA; Chiswell K; Young L; Chiu A; Liu L; Webb L; Carlisle M; Friedman D; Wang TY
    JAMA Netw Open; 2023 Jun; 6(6):e2317156. PubMed ID: 37285155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.
    Schwartz J; Merrill S; de Leon N; Thompson A; Fang M
    J Hosp Med; 2017 Jul; 12(7):544-550. PubMed ID: 28699943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
    Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: a single-center retrospective cohort study.
    Miyazaki M; Matsuo K; Uchiyama M; Nakamura Y; Sakamoto Y; Misaki M; Tokura K; Jimi S; Okamura K; Adachi S; Yamamoto T; Shirai K; Urata H; Imakyure O
    J Pharm Health Care Sci; 2020; 6():2. PubMed ID: 32071730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Apixaban Prescribing Patterns for Nonvalvular Atrial Fibrillation in Hospitalized Patients.
    Gibson CM; Smith CB; Davis S; Scalese MJ
    Ann Pharmacother; 2018 Jan; 52(1):54-59. PubMed ID: 28799408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Oral Anticoagulants in Long-term Care Facilities: Rates of FDA-Approved Dosing.
    Whitney B; Sakel K; Lengel AJ
    Sr Care Pharm; 2022 Jun; 37(6):215-220. PubMed ID: 35610769
    [No Abstract]   [Full Text] [Related]  

  • 8. Dosing challenges with direct oral anticoagulants in the elderly: a retrospective analysis.
    Fava JP; Starr KM; Ratz D; Clemente JL
    Ther Adv Drug Saf; 2018 Aug; 9(8):405-414. PubMed ID: 30364869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
    Barra ME; Fanikos J; Connors JM; Sylvester KW; Piazza G; Goldhaber SZ
    Am J Med; 2016 Nov; 129(11):1198-1204. PubMed ID: 27341955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health system.
    Grant SJ; Kothari S; Gimotty PA; Gooneratne NS; Cuker A
    J Thromb Thrombolysis; 2018 Jul; 46(1):1-6. PubMed ID: 29611105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of risk factors for inappropriate and suboptimal initiation of direct oral anticoagulants.
    Howard M; Lipshutz A; Roess B; Hawes E; Deyo Z; Burkhart JI; Moll S; Shilliday BB
    J Thromb Thrombolysis; 2017 Feb; 43(2):149-156. PubMed ID: 27757787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a pharmacist-led outpatient direct oral anticoagulant service.
    Ashjian E; Kurtz B; Renner E; Yeshe R; Barnes GD
    Am J Health Syst Pharm; 2017 Apr; 74(7):483-489. PubMed ID: 28336758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.
    Elewa H; El-Makaty H; Ali Z
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):155-161. PubMed ID: 28978236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation.
    Lavoie K; Turgeon MH; Brais C; Larochelle J; Blais L; Farand P; Letemplier G; Perreault S; Beauchesne MF
    J Atr Fibrillation; 2016 Dec; 9(4):1478. PubMed ID: 29250254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant.
    Minhas AS; Jiang Q; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Krol GD; Kaatz S; Froehlich JB; Barnes GD
    J Thromb Thrombolysis; 2016 Nov; 42(4):566-72. PubMed ID: 27217043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of self-reported adherence to direct oral anticoagulation in a population of elderly men and women with non-valvular atrial fibrillation.
    Rossi AP; Facchinetti R; Ferrari E; Nori N; Sant S; Masciocchi E; Zoico E; Fantin F; Mazzali G; Zamboni M
    J Thromb Thrombolysis; 2018 Aug; 46(2):139-144. PubMed ID: 29761426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and the EHRA Practical Guide.
    Capiau A; De Backer T; Grymonprez M; Lahousse L; Van Tongelen I; Mehuys E; Boussery K
    Int J Cardiol; 2021 Apr; 328():97-103. PubMed ID: 33279589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Trends in Ambulatory Oral Anticoagulant Use.
    Barnes GD; Lucas E; Alexander GC; Goldberger ZD
    Am J Med; 2015 Dec; 128(12):1300-5.e2. PubMed ID: 26144101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants for under- and overdosing of direct oral anticoagulants and physicians' implementation of clinical pharmacists' recommendations.
    Moudallel S; Cornu P; Dupont A; Steurbaut S
    Br J Clin Pharmacol; 2022 Feb; 88(2):753-763. PubMed ID: 34331720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations.
    Stacy ZA; Richter SK
    Ther Adv Cardiovasc Dis; 2018 Sep; 12(9):247-262. PubMed ID: 30081727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.